Editorial comment--an approach to the estimation of the risk of TTP during clopidogrel therapy.
Jonas
Saran
S
Grieco
Giacinto
G
D000077144:Clopidogrel; D004363:Drug Utilization / Q000706:statistics & numerical data; D006801:Humans; D015994:Incidence; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects*; D011358:Product Surveillance, Postmarketing / Q000706:statistics & numerical data; D011697:Purpura, Thrombotic Thrombocytopenic / Q000139:chemically induced* / Q000453:epidemiology; D018570:Risk Assessment; D013988:Ticlopidine / Q000009:adverse effects* / Q000031:analogs & derivatives*; D014481:United States / Q000453:epidemiology
D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D013988:Ticlopidine